VCEL
Vericel Corp
NASDAQ · Healthcare · Biotechnology · US
$40.37
+0.60%Forward multiples
Based on analyst estimates
- P/E forward
- 51.00x
- P/E 2026E
- 75.89x
- P/E 2027E
- 46.94x
- P/E 2028E
- 30.40x
- P/S forward
- 5.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- 84.10x
- PEG TTM
- 1.30x
- Price / book
- 5.59x
- Price / sales
- 6.75x
- Price / cash flow
- 29.67x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 6.52x
- EV / EBITDA
- 51.47x
- EV / EBIT
- 109.53x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026